BioWorld - Sunday, July 12, 2026

brexpiprazole

15 items

predetermined change control plan

15 items

lnps

15 items

antiviral

15 items

17beta-hsd13 inhibitors

15 items

amber therapeutics ltd.

15 items

tenosynovial giant cell tumors

15 items

glp-1r/gipr/gcgr agonists

15 items

irak-4 inhibitors

15 items

duality biologics co. ltd.

15 items

university of florida

15 items

esmo 2023

15 items

licensing deal

15 items

tnbc

15 items

pulseselect

15 items

patient monitoring

15 items

savr

15 items

autophagy

15 items

blood cancer

15 items

biofourmis inc.

15 items